["{\n\"step_by_step_thinking\": \"According to the document 'Leukocyte reduction in blood component therapy', leukocytes are the chief cause of alloimmunization to human leukocyte antigen (HLA) and leukocyte-specific antigens in transfusion recipients. Leukocytes can also cause febrile reactions, platelet refractoriness, and acute lung injury. To reduce the chances of febrile non-hemolytic transfusion reaction (FNHTR), leukocyte reduction should be done before transfusion.\",\n\"answer_choice\": \"C\"\n}"]